# FDA Inspection 1173805 - Christopher P. Recknor MD - June 10, 2022

Source: https://www.keypedia.com/records/fda_inspections/christopher-p-recknor-md/5f637fa3-1ddf-4190-8a70-4e3ec8c7d3a9
Source feed: FDA_Inspections

> FDA Inspection 1173805 for Christopher P. Recknor MD on June 10, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1173805
- Company Name: Christopher P. Recknor MD
- Inspection Date: 2022-06-10
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1098785 - 2019-07-18](https://www.keypedia.com/records/fda_inspections/christopher-p-recknor-md/32e486b6-ba06-4824-952e-69e0625383c8)
- [FDA Inspection 1016324 - 2017-05-01](https://www.keypedia.com/records/fda_inspections/christopher-p-recknor-md/4071e8e6-2ad9-4464-994f-8977a653d509)
- [FDA Inspection 995255 - 2016-12-16](https://www.keypedia.com/records/fda_inspections/christopher-p-recknor-md/c4c959d3-d483-4a19-8bcd-ed29fa03f99e)

Company: https://www.keypedia.com/companies/christopher-p-recknor-md/76de8d53-5206-481a-a161-45e08129f8b6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c